Literature DB >> 18794852

Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation.

Paul Fiorilli1, Darren Partridge, Izabela Staniszewska, Jin Y Wang, Maja Grabacka, Kelvin So, Cezary Marcinkiewicz, Krzysztof Reiss, Kamel Khalili, Sidney E Croul.   

Abstract

Medulloblastoma spreads by leptomeningeal dissemination rather than by infiltration that characterizes other CNS tumors, eg, gliomas. This study represents an initial attempt to identify both the molecules that mediate medulloblastoma adhesion to leptomeninges and the pathways that are key to survival and proliferation of tumor following adhesion. As a first step in molecule identification, we produced adhesion of D283 medulloblastoma cells to the extracellular matrix (ECM) of H4 glioma cells in vitro. Within this context, D283 cells preferentially expressed the alpha9 and beta1 integrin subunits; antibody and disintegrin blockade of alpha9 and beta1 binding eliminated the adhesion. The H4 ECM was enriched in tenascin, a binding partner for the alpha9beta1 integrin heterodimer. Purified tenascin-C supported D283 cell adhesion. The adhesion was blocked by antibodies to alpha9 and beta1 integrin. In vivo data were similar; immunohistochemistry of primary human medulloblastomas with leptomeningeal extension demonstrated increased expression of alpha9 and beta1 integrins as well as tenascin at the interface of brain and leptomeningeal tumor. These data suggest that tumor-cell expressions of alpha9 and beta1 integrins in combination with extracellular tenascin are necessary for medulloblastoma adhesion to the leptomeninges. As a first step in the identification of pathways that mediate survival and proliferation of tumor following adhesion, we demonstrated that adhesion to H4 ECM was associated with survival and proliferation of D283 cells as well as activation of the MAPK pathway in a growth factor deficient environment. Antibody blockade of alpha9 and beta1 integrin binding that eliminated adhesion also eliminated the in vitro survival benefit. These data suggest that adhesion of medulloblastoma to the meninges is necessary for the survival and proliferation of these tumor cells at the secondary site.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794852      PMCID: PMC2679155          DOI: 10.1038/labinvest.2008.89

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  60 in total

Review 1.  New insights into the diversity and function of neuronal immunoglobulin superfamily molecules.

Authors:  Genevieve Rougon; Oliver Hobert
Journal:  Annu Rev Neurosci       Date:  2003-02-13       Impact factor: 12.449

Review 2.  Synaptic adhesion molecules.

Authors:  Masahito Yamagata; Joshua R Sanes; Joshua A Weiner
Journal:  Curr Opin Cell Biol       Date:  2003-10       Impact factor: 8.382

3.  Connection between integrins and cell activation in rat adrenal glomerulosa cells: a role for Arg-Gly-Asp peptide in the activation of the p42/p44(mapk) pathway and intracellular calcium.

Authors:  Shirley Campbell; Melissa Otis; Mylène Côté; Nicole Gallo-Payet; Marcel Daniel Payet
Journal:  Endocrinology       Date:  2003-04       Impact factor: 4.736

4.  Construction of an artificial blood vessel wall from cultured endothelial and smooth muscle cells.

Authors:  P A Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

5.  Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brain.

Authors:  Sonia Franciosi; Rita De Gasperi; Dara L Dickstein; Daniel F English; Anne B Rocher; William G M Janssen; Daniel Christoffel; Miguel A Gama Sosa; Patrick R Hof; Joseph D Buxbaum; Gregory A Elder
Journal:  J Neurosci Methods       Date:  2007-02-25       Impact factor: 2.390

6.  E, N-cadherins and beta-catenin expression in medulloblastoma and atypical teratoid/rhabdoid tumor.

Authors:  Satoshi Utsuki; Hidehiro Oka; Yuichi Sato; Benio Tsutiya; Kouji Kondo; Yoshinori Tanizaki; Satoshi Tanaka; Kiyotaka Fujii
Journal:  Neurol Med Chir (Tokyo)       Date:  2004-08       Impact factor: 1.742

Review 7.  Signalling via integrins: implications for cell survival and anticancer strategies.

Authors:  Stephanie Hehlgans; Michael Haase; Nils Cordes
Journal:  Biochim Biophys Acta       Date:  2006-10-04

8.  Structural requirements of MLD-containing disintegrins for functional interaction with alpha 4 beta 1 and alpha 9 beta1 integrins.

Authors:  Stanislawa Bazan-Socha; Dariusz G Kisiel; Brad Young; R David G Theakston; Juan J Calvete; Dean Sheppard; Cezary Marcinkiewicz
Journal:  Biochemistry       Date:  2004-02-17       Impact factor: 3.162

Review 9.  Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors.

Authors:  Tobey J MacDonald; Brian R Rood; Maria R Santi; Gilbert Vezina; Kimberly Bingaman; Philip H Cogen; Roger J Packer
Journal:  Oncologist       Date:  2003

Review 10.  Recent advances in the treatment of malignant astrocytoma.

Authors:  David A Reardon; Jeremy N Rich; Henry S Friedman; Darell D Bigner
Journal:  J Clin Oncol       Date:  2006-03-10       Impact factor: 44.544

View more
  26 in total

Review 1.  Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function.

Authors:  Helge Wiig; Doruk Keskin; Raghu Kalluri
Journal:  Matrix Biol       Date:  2010-08-18       Impact factor: 11.583

2.  Effects of integrins on laminin chemotaxis by hepatocellular carcinoma cells.

Authors:  Bian-Hong Fu; Ze-Zhi Wu; Jian Qin
Journal:  Mol Biol Rep       Date:  2009-09-21       Impact factor: 2.316

3.  Internal relationship between symptomatic venous thromboembolism and risk factors: up-regulation of integrin β1, β2 and β3 levels.

Authors:  Qianglin Duan; Lemin Wang; Fan Yang; Jue Li; Yanli Song; Zhu Gong; Guiyuan Li; Haoming Song; Xiaoyu Zhang; Zugang Shen; Anthony Dart
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

4.  Activation of circulated immune cells and inflammatory immune adherence are involved in the whole process of acute venous thrombosis.

Authors:  Le-Min Wang; Qiang-Lin Duan; Fan Yang; Xiang-Hua Yi; Yu Zeng; Hong-Yan Tian; Wei Lv; Yun Jin
Journal:  Int J Clin Exp Med       Date:  2014-03-15

5.  Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models.

Authors:  Leslie L Muldoon; Seymur Gahramanov; Xin Li; Deborah J Marshall; Dale F Kraemer; Edward A Neuwelt
Journal:  Neuro Oncol       Date:  2010-12-01       Impact factor: 12.300

6.  Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors.

Authors:  Luydmila A Mostovich; Tatiana Y Prudnikova; Aleksandr G Kondratov; Dina Loginova; Pavel V Vavilov; Valentina I Rykova; Sergei V Sidorov; Tatiana V Pavlova; Vladimir I Kashuba; Eugene R Zabarovsky; Elvira V Grigorieva
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

7.  Serum free cultured bone marrow mesenchymal stem cells as a platform to characterize the effects of specific molecules.

Authors:  Leonardo Solmesky; Sharon Lefler; Jasmine Jacob-Hirsch; Shlomo Bulvik; Gideon Rechavi; Miguel Weil
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

Review 8.  Three-dimensional culture systems in cancer research: Focus on tumor spheroid model.

Authors:  Sritama Nath; Gayathri R Devi
Journal:  Pharmacol Ther       Date:  2016-04-08       Impact factor: 12.310

Review 9.  Medulloblastoma: recurrence and metastasis.

Authors:  Donya Aref; Sidney Croul
Journal:  CNS Oncol       Date:  2013-07

Review 10.  Applications of snake venom components to modulate integrin activities in cell-matrix interactions.

Authors:  Cezary Marcinkiewicz
Journal:  Int J Biochem Cell Biol       Date:  2013-06-26       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.